PMID: 9440437Jan 24, 1998Paper

Effectiveness of influenza vaccine in reducing hospital admissions in people with diabetes

Epidemiology and Infection
A J ColquhounN T Raymond

Abstract

The effectiveness of influenza vaccination in reducing hospitalization of people with diabetes for influenza, pneumonia, or diabetic events during influenza epidemics was assessed in a case control study in Leicestershire, England. Cases were 80 patients on the Leicestershire Diabetes Register who were admitted and discharged from hospital with International Classification of Disease codes for pneumonia, bronchitis, influenza, diabetic ketoacidosis, coma and diabetes, without mention of complications, during the influenza epidemics of 1989-90 and 1993. One hundred and sixty-controls, who were not admitted to hospital during this period, were randomly selected from the Register. Immunization against influenza was assessed in 37 cases and 77 controls for whom consent was obtained to access their clinical notes and for whom notes were available. Significant association was detected between reduction in hospitalization and influenza vaccination during the period immediately preceding an epidemic. Multiple logistic regression analysis estimated that influenza vaccination reduced hospital admissions by 79% (95% CI 19-95%) during the two epidemics, after adjustment for potential confounders.

Citations

Dec 4, 2003·Lancet·Karl G NicholsonMaria Zambon
Sep 5, 2003·Journal of Diabetes and Its Complications·Dilek KiliçLevent Doğanci
Jul 30, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Eelko HakKristin L Nichol
Jan 30, 2003·American Journal of Public Health·Leonard E Egede, Deyi Zheng
Nov 8, 2002·Drugs·Eelko HakTheo J M Verheij
Jan 4, 2013·Diabetes Care·UNKNOWN American Diabetes Association
Apr 9, 2001·Aging : Clinical and Experimental Research·F PregliascoA Belloni
Jan 20, 2009·Journal of Cancer Research and Clinical Oncology·Yu TaiKow-Tong Chen
Dec 4, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Chong-Shan WangPesus Chou
Mar 1, 2006·Expert Opinion on Biological Therapy·G W Rose, C L Cooper
Dec 23, 2015·International Journal of Environmental Research and Public Health·Ghada El Khoury, Pascale Salameh
May 31, 2011·Autoimmunity Reviews·Micha LöbermannEmil C Reisinger
Dec 24, 2015·Diabetes Care·UNKNOWN American Diabetes Association
Dec 15, 2007·The Journal of Infection·A Karthikeyan, J C Agwu
Nov 24, 2007·Diabetes Research and Clinical Practice·Rodrigo Jiménez-GarcíaAngel Gil de Miguel
Aug 19, 2014·Reviews in Medical Virology·P D Griffiths
May 19, 2009·The Journal of Infection·Patricia R BlankThomas D Szucs
Apr 28, 2004·American Journal of Preventive Medicine·Matthew M DavisSarah J Clark
Feb 14, 2012·Human Vaccines & Immunotherapeutics·Teresa Rodriguez-BlancoNeus Saun
May 21, 2015·Emerging Infectious Diseases·Direk LimmathurotsakulUNKNOWN Steering Group on Melioidosis Vaccine Development
Jan 19, 2012·Human Vaccines & Immunotherapeutics·Paloma Carrillo-SantistevePier Luigi Lopalco
Apr 15, 2015·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Yehuda HandelsmanFarhad Zangeneh
Dec 25, 2003·Diabetes Care·UNKNOWN American Diabetes Association
Jan 10, 2008·Diabetes Care·UNKNOWN American Diabetes Association
Jan 5, 2002·Diabetes Care·UNKNOWN American Diabetes Association
Jan 4, 2012·Diabetes Care·UNKNOWN American Diabetes Association
Jan 6, 2009·Diabetes Care·UNKNOWN American Diabetes Association
Jan 29, 2010·Diabetes Care·UNKNOWN American Diabetes Association
Jan 14, 2011·Diabetes Care·UNKNOWN American Diabetes Association
Dec 28, 2002·Diabetes Care·UNKNOWN American Diabetes Association
Jul 27, 2005·Diabetes Care·Rodrigo Jiménez-GarcíaAngel Gil de Miguel
Dec 25, 2004·Diabetes Care·UNKNOWN American Diabetes Association
Jun 9, 2009·Diabetes Care·Florence J DalloJim P Stimpson
Dec 21, 2013·Diabetes Care·UNKNOWN American Diabetes Association
Nov 7, 2016·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·Cornelius RemschmidtThomas Mertens
Dec 17, 2016·Diabetes Care·UNKNOWN American Diabetes Association

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.